skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Treatment of tumors with genetically engineered herpes virus

Abstract

Disclosed are methods for treating cancer by administering an effective amount of a modified Herpes simplex virus.

Inventors:
; ;
Issue Date:
Research Org.:
University of Alabama Research Foundation
Sponsoring Org.:
USDOE
OSTI Identifier:
1080289
Patent Number(s):
8318691
Application Number:
12/802,443
Assignee:
Arch Development Corporation (Chicago, IL); UAB Research Foundation (Birmingham, AL)
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES
DOE Contract Number:  
FG05-93ER61654
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Weichselbaum, Ralph R, Roizman, Bernard, and Whitley, Richard J. Treatment of tumors with genetically engineered herpes virus. United States: N. p., 2012. Web.
Weichselbaum, Ralph R, Roizman, Bernard, & Whitley, Richard J. Treatment of tumors with genetically engineered herpes virus. United States.
Weichselbaum, Ralph R, Roizman, Bernard, and Whitley, Richard J. Tue . "Treatment of tumors with genetically engineered herpes virus". United States. https://www.osti.gov/servlets/purl/1080289.
@article{osti_1080289,
title = {Treatment of tumors with genetically engineered herpes virus},
author = {Weichselbaum, Ralph R and Roizman, Bernard and Whitley, Richard J},
abstractNote = {Disclosed are methods for treating cancer by administering an effective amount of a modified Herpes simplex virus.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2012},
month = {11}
}

Patent:

Save / Share:

Works referenced in this record:

Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation.
journal, May 1991


Programmed cell death: Apoptosis and oncogenesis
journal, June 1991


Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras.
journal, September 1984


Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation
journal, May 1998


Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis
journal, February 1991


Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment.
journal, January 1985


Sequence of MyD116 cDNA: a novel myeloid differentiation primary response gene induced by IL6
journal, January 1990


Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
journal, December 1997


The Herpes Simplex Virus Type 2 (HG52) Variant JH2604 Has a 1488 bp Deletion which Eliminates Neurovirulence in Mice
journal, November 1989


Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA.
journal, January 1986


Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.
journal, June 1993


Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies.
journal, January 1984


The basic science of gene therapy
journal, May 1993


Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments.
journal, July 1980


Size, Composition, and Structure of the Deoxyribonucleic Acid of Herpes Simplex Virus Subtypes 1 and 2
journal, January 1971


The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency
journal, September 1991


Why do neurons die when deprived of trophic factor?
journal, September 1989


In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020: Construction and Evaluation in Rodents
journal, September 1988


Mapping of functional and antigenic domains of the alpha 4 protein of herpes simplex virus 1.
journal, January 1988


Restoration of Wild-type Pathogenicity to an Attenuated DNA Polymerase Mutant of Herpes Simplex Virus Type 1
journal, November 1986


Serial passage of embryonic human astrocytes in serum-free, hormone-supplemented medium
journal, January 1991


Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS.
journal, January 1986


p53 status and the efficacy of cancer therapy in vivo
journal, November 1994


Characterization of Herpes Simplex Virus Strains Differing in their Effects on Social Behaviour of Infected Cells
journal, May 1968


2021 Enhanced replication of attenuated HSV-1 in irradiated human glioma xenografts
journal, January 1997


Cell suicide: by ICE, not fire
journal, February 1994


The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1
journal, July 1988


Vaccine potential of a live avirulent herpes simplex virus
journal, August 1986


Characterization of a viable, noninverting herpes simplex virus 1 genome derived by insertion and deletion of sequences at the junction of components L and S.
journal, May 1983


Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1
journal, January 1986


Enhancement of Gene Therapy Specificity for Diffuse Colon Carcinoma Liver Metastases with Recombinant Herpes Simplex Virus
journal, January 1996


Site-specific cleavage/packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA
journal, March 1982


p53 mutations in human cancers
journal, July 1991


The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors.
journal, October 1996


Prevention of vertebrate neuronal death by the crmA gene
journal, February 1994


Experimental therapy of human glioma by means of a genetically engineered virus mutant
journal, May 1991


The Fas death factor
journal, March 1995


bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
journal, November 1991


Site-specific inversion sequence of the herpes simplex virus genome: Domain and structural features
journal, November 1981


The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice
journal, October 1978


Characterization of the IE110 Gene of Herpes Simplex Virus Type 1
journal, November 1986


Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17
journal, April 1992


Prevention of apoptosis by a baculovirus gene during infection of insect cells
journal, November 1991


A simple method for displaying the hydropathic character of a protein
journal, May 1982


Location and Orientation of Homologous Sequences in the Genomes of Five Herpesviruses
journal, September 1983


Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions.
journal, January 1975


Spatial and temporal control of gene therapy using ionizing radiation
journal, August 1995


Inverted Repetitions in the Chromosome of Herpes Simplex Virus
journal, January 1974


bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
journal, November 1991


Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus I
journal, January 1988


An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
journal, October 1996


Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
journal, July 1996


DNA sequencing with chain-terminating inhibitors
journal, December 1977


Infections with Herpes Simplex Viruses
journal, March 1986


Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components.
journal, November 1975


Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer
journal, March 1990


Multipotent neural cell lines can engraft and participate in development of mouse cerebellum
journal, January 1992


Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.
journal, February 1995


Restriction of Herpes Simplex Virus by Macrophages
journal, January 1971


Isolation of Latent Herpes Simplex Virus from the Superior Cervical and Vagus Ganglions of Human Beings
journal, May 1978


Temporal Cluster of Herpes Simplex Encephalitis: Investigation by Restriction Endonuclease Cleavage of Viral DNA
journal, April 1980


Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain
journal, August 1991


Mechanisms and genes of cellular suicide
journal, March 1995


Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA.
journal, February 1982


Gene therapy - promises, problems and prospects
journal, September 1997